Scilex (SCLX) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $2.83, +0.35% vs the prior close of $2.82.
- Volume 29.52K shares, 0.7x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
SCLX rises 0.4% to $2.83. Closed at $2.83, +0.35% vs the prior close of $2.82. Day range $2.77–$2.89, opened at $2.89.
SCLX daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — SCLX rises 0.4% to $2.83
- Closed at $2.83, +0.35% vs the prior close of $2.82. Day range $2.77–$2.89, opened at $2.89.
- Volume was 29.52K shares, 0.7x its 50-day average of 41.01K.
- Price is -43.5% vs its 50-day average ($5.01) and -49.4% vs its 200-day average ($5.60).
- 52-week range $2.62–$16.81; today's close sits at 2% of that range, 83.2% below the 52-week high.
Oct 15, 2026 — SCLX dips 1.1% to $2.82
- Closed at $2.82, -1.05% vs the prior close of $2.85. Day range $2.77–$2.85, opened at $2.83.
- Volume was 12.50K shares, 0.3x its 50-day average of 41.75K — lighter than usual.
- Price is -44.6% vs its 50-day average ($5.09) and -49.8% vs its 200-day average ($5.62).
- 52-week range $2.62–$16.81; today's close sits at 1% of that range, 83.2% below the 52-week high.
Oct 14, 2026 — SCLX dips 1.0% to $2.85
- Closed at $2.85, -1.04% vs the prior close of $2.88. Day range $2.81–$2.95, opened at $2.88.
- Volume was 26.70K shares, 0.6x its 50-day average of 42.70K.
- Price is -44.8% vs its 50-day average ($5.16) and -49.6% vs its 200-day average ($5.65).
- 52-week range $2.62–$16.81; today's close sits at 2% of that range, 83.0% below the 52-week high.
Oct 13, 2026 — SCLX rises 2.9% to $2.88
- Closed at $2.88, +2.86% vs the prior close of $2.80. Day range $2.79–$3.22, opened at $2.81.
- Volume was 33.90K shares, 0.8x its 50-day average of 42.65K.
- Price is -45.0% vs its 50-day average ($5.24) and -49.3% vs its 200-day average ($5.68).
- 52-week range $2.62–$16.81; today's close sits at 2% of that range, 82.9% below the 52-week high.
Oct 12, 2026 — SCLX slides 4.1% to $2.80, a 52-week low, 4 down days in a row
- Closed at $2.80, -4.11% vs the prior close of $2.92. Day range $2.80–$2.95, opened at $2.92.
- Volume was 33.80K shares, 0.8x its 50-day average of 43.97K.
- Price is -47.3% vs its 50-day average ($5.31) and -51.0% vs its 200-day average ($5.71).
- 52-week range $2.62–$16.81; today's close sits at 1% of that range, 83.3% below the 52-week high.
- That makes 4 straight losses.
Oct 9, 2026 — SCLX dips 1.4% to $2.92, a 52-week low, 3 down days in a row
- Closed at $2.92, -1.35% vs the prior close of $2.96. Day range $2.86–$3.11, opened at $2.96.
- Volume was 49.70K shares, 1.1x its 50-day average of 45.19K.
- Price is -45.8% vs its 50-day average ($5.39) and -49.1% vs its 200-day average ($5.74).
- 52-week range $2.62–$16.81; today's close sits at 2% of that range, 82.6% below the 52-week high.
- That makes 3 straight losses.
Oct 8, 2026 — SCLX slides 15.2% to $2.96, a 52-week low on 3.2x normal volume
- Closed at $2.96, -15.19% vs the prior close of $3.49. Day range $2.90–$3.59, opened at $3.49.
- Volume was 140.80K shares, 3.2x its 50-day average of 44.38K — unusually heavy trading.
- Price is -45.8% vs its 50-day average ($5.46) and -48.7% vs its 200-day average ($5.77).
- 52-week range $2.62–$16.81; today's close sits at 2% of that range, 82.4% below the 52-week high.
Oct 7, 2026 — SCLX slides 11.9% to $3.49, a 52-week low on 1.8x normal volume
- Closed at $3.49, -11.87% vs the prior close of $3.96. Day range $3.44–$3.90, opened at $3.90.
- Volume was 82.10K shares, 1.8x its 50-day average of 44.98K — unusually heavy trading.
- Price is -36.9% vs its 50-day average ($5.53) and -39.8% vs its 200-day average ($5.80).
- 52-week range $2.62–$16.81; today's close sits at 6% of that range, 79.2% below the 52-week high.
Oct 6, 2026 — SCLX jumps 3.7% to $3.96
- Closed at $3.96, +3.66% vs the prior close of $3.82. Day range $3.79–$4.05, opened at $3.87.
- Volume was 57.90K shares, 1.3x its 50-day average of 46.23K.
- Price is -29.3% vs its 50-day average ($5.60) and -32.0% vs its 200-day average ($5.82).
- 52-week range $2.62–$16.81; today's close sits at 9% of that range, 76.4% below the 52-week high.
Oct 5, 2026 — SCLX slides 5.9% to $3.82, a 3-month low, 3 down days in a row
- Closed at $3.82, -5.91% vs the prior close of $4.06. Day range $3.81–$4.49, opened at $4.13.
- Volume was 59.60K shares, 1.3x its 50-day average of 47.61K.
- Price is -32.5% vs its 50-day average ($5.66) and -34.7% vs its 200-day average ($5.85).
- 52-week range $2.62–$16.81; today's close sits at 8% of that range, 77.3% below the 52-week high.
- That makes 3 straight losses.
Oct 2, 2026 — SCLX slides 7.9% to $4.06, a 3-month low on 2.3x normal volume
- Closed at $4.06, -7.94% vs the prior close of $4.41. Day range $4.00–$4.59, opened at $4.40.
- Volume was 107.80K shares, 2.3x its 50-day average of 46.64K — unusually heavy trading.
- Price is -29.0% vs its 50-day average ($5.72) and -31.0% vs its 200-day average ($5.88).
- 52-week range $2.62–$16.81; today's close sits at 10% of that range, 75.9% below the 52-week high.
SCLX latest news & SEC filings
Every SEC filing by or about SCLX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 29, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Aug 24, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 24, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $7.64M (prior year $9.90M) (-22.8% vs Jun 30, 2025)
- Net income: -$114.99M (prior year -$44.05M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$16.65 (prior year -$7.42) (loss widened vs Jun 30, 2025)
Aug 12, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Jul 22, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 2.01 — Completed an acquisition or sale of assets.
Jul 7, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 7, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 3.02 — Sold unregistered shares.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Jun 30, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Jun 29, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 3.02 — Sold unregistered shares.
Jun 26, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jun 26, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Things to know before you trade SCLX
- Last results release: Oct 8, 2024 (8-K Item 2.02). Previous ones: Aug 1, 2024, Jul 1, 2024, Apr 16, 2024. Based on that rhythm, the next report is likely around Jan 7, 2025 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 4.10% (largest 15.2%). That is a volatile stock.
- Liquidity: about 43.57K shares (≈$123.29K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $2.83 vs a range of $2.62–$16.81 (2% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1606:1000 on Jun 16, 2026, 1:35 on Apr 15, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 12 sales; latest: Holding Co Scilex sold 9,657,300 shares on Dec 30, 2025.
- Latest filings: 8-K Sep 29, 2026; 10-Q Aug 14, 2026; 8-K Aug 12, 2026.
- Share count: 8.49M shares outstanding (Aug 10, 2026), +22.1% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Biological Products, (No Diagnostic Substances).
SCLX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 2.89 | 2.89 | 2.77 | 2.83 | 29.52K |
| Oct 15, 2026 | 2.83 | 2.85 | 2.77 | 2.82 | 12.50K |
| Oct 14, 2026 | 2.88 | 2.95 | 2.81 | 2.85 | 26.70K |
| Oct 13, 2026 | 2.81 | 3.22 | 2.79 | 2.88 | 33.90K |
| Oct 12, 2026 | 2.92 | 2.95 | 2.80 | 2.80 | 33.80K |
| Oct 9, 2026 | 2.96 | 3.11 | 2.86 | 2.92 | 49.70K |
| Oct 8, 2026 | 3.49 | 3.59 | 2.90 | 2.96 | 140.80K |
| Oct 7, 2026 | 3.90 | 3.90 | 3.44 | 3.49 | 82.10K |
| Oct 6, 2026 | 3.87 | 4.05 | 3.79 | 3.96 | 57.90K |
| Oct 5, 2026 | 4.13 | 4.49 | 3.81 | 3.82 | 59.60K |
| Oct 2, 2026 | 4.40 | 4.59 | 4.00 | 4.06 | 107.80K |
| Oct 1, 2026 | 4.49 | 4.88 | 4.40 | 4.41 | 16.10K |
| Sep 30, 2026 | 4.42 | 4.69 | 4.40 | 4.45 | 17.50K |
| Sep 29, 2026 | 4.48 | 4.53 | 4.36 | 4.41 | 12.00K |
| Sep 28, 2026 | 4.89 | 4.90 | 4.45 | 4.49 | 73.20K |
| Sep 25, 2026 | 5.37 | 5.37 | 4.83 | 4.89 | 42.80K |
| Sep 24, 2026 | 5.06 | 5.15 | 4.92 | 4.94 | 27.30K |
| Sep 23, 2026 | 5.35 | 5.35 | 5.10 | 5.10 | 8.70K |
| Sep 22, 2026 | 5.12 | 5.42 | 5.12 | 5.35 | 17.90K |
| Sep 21, 2026 | 5.02 | 5.31 | 5.00 | 5.16 | 21.50K |
About Scilex
Scilex (SCLX) is listed on the Nasdaq and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in PALO ALTO, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1820190.
SCLX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Jay Chun | Director | Oct 9, 2025 |
| Dorman Followwill | Director | Oct 9, 2025 |
| Henry Ji | Exec Chair, CEO and President | Apr 20, 2026 |
| Stephen Hoi Ma | CFO, COO and Secretary | Apr 20, 2026 |
| Yue Alexander Wu | Director | Oct 9, 2025 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Henry Ji | Exec Chair, CEO and President | Apr 20, 2026 |
| Stephen Hoi Ma | CFO, COO and Secretary | Apr 20, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Dec 30, 2025 | Holding Co Scilex | Sale | 9,657,300 | $0.54 |
| Dec 30, 2025 | Holding Co Scilex | Sale | 9,657,300 | $0.54 |
| Dec 30, 2025 | Holding Co Scilex | Sale | 9,657,300 | $0.54 |
| Dec 30, 2025 | Holding Co Scilex | Sale | 9,657,300 | $0.54 |
| Dec 29, 2025 | Holding Co Scilex | Sale | 7,310,984 | $0.66 |
| Dec 29, 2025 | Holding Co Scilex | Sale | 7,310,984 | $0.66 |
| Dec 29, 2025 | Holding Co Scilex | Sale | 7,310,984 | $0.66 |
| Dec 29, 2025 | Holding Co Scilex | Sale | 7,310,984 | $0.66 |
| Dec 26, 2025 | Holding Co Scilex | Sale | 3,689,016 | $0.75 |
| Dec 26, 2025 | Holding Co Scilex | Sale | 3,689,016 | $0.75 |
| Dec 26, 2025 | Holding Co Scilex | Sale | 3,689,016 | $0.75 |
| Dec 26, 2025 | Holding Co Scilex | Sale | 3,689,016 | $0.75 |
SCLX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $30.25M | $-374.05M | -36.48 | $3.82M |
| Dec 31, 2024 | $56.59M | $-72.81M | -8.05 | $19.35M |
| Dec 31, 2023 | $46.74M | $-114.33M | -1.28 | $-20.71M |
| Dec 31, 2022 | $38.03M | $-23.36M | -0.17 | $-21.26M |
| Dec 31, 2021 | $31.32M | $-88.42M | -0.67 | $-28.66M |
Latest balance sheet: total assets $253.56M, total liabilities $564.05M, cash $566.00K (as of Jun 30, 2026).
SCLX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Oct 8, 2024 | 8-K Item 2.02 (results) | — |
| Aug 1, 2024 | 8-K Item 2.02 (results) | — |
| Jul 1, 2024 | 8-K Item 2.02 (results) | — |
| Apr 16, 2024 | 8-K Item 2.02 (results) | — |
| Mar 5, 2024 | 8-K Item 2.02 (results) | — |
| Jan 2, 2024 | 8-K Item 2.02 (results) | — |
| Dec 1, 2023 | 8-K Item 2.02 (results) | — |
| Nov 1, 2023 | 8-K Item 2.02 (results) | — |
| Oct 2, 2023 | 8-K Item 2.02 (results) | — |
| Sep 11, 2023 | 8-K Item 2.02 (results) | — |
| Jul 5, 2023 | 8-K Item 2.02 (results) | — |
| Jun 1, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Kodiak Sciences (KOD)Greenland Mines (GRML)Halozyme Therapeutics (HALO)Biogen (BIIB)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on SCLX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.